BNGO
NASDAQ
US
Bionano Genomics, Inc. - Common Stock
$1.20
▲ +$0.01
(+0.84%)
Vol 119K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$15.6M
ROE
-86.4%
Margin
-134.4%
D/E
7.52
Beta
1.70
52W
$1–$23
Wall Street Consensus
9 analysts · Apr 20262
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%
Next Report
May 12, 2026
EPS Estimate: $-0.77
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.77 | — | — |
| Dec 2025 | $-1.43 | $-0.03 | +$1.40 |
| Sep 2025 | $-1.95 | $-1.59 | +$0.36 |
| Jun 2025 | $-2.46 | $-1.99 | +$0.47 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $6.1M | $8.2M | $6.5M | $6.7M | $7.4M |
| Net Income | -$44.2M | -$20.1M | -$3.1M | -$6.9M | -$8.5M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -167.2% | -157.3% | -167.2% | -167.2% | -167.2% | -86.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -101.8% | -294.1% | -271.0% | -271.0% | -271.0% | -134.4% |
| Gross Margin | 51.6% | 1.7% | 5.0% | 5.0% | 5.0% | 46.0% |
| D/E Ratio | 8.30 | 7.85 | 8.30 | 8.30 | 8.30 | 7.52 |
| Current Ratio | 1.76 | 1.70 | 1.76 | 1.76 | 1.76 | 2.12 |
Key Ratios
ROA (TTM)
-49.8%
P/S (TTM)
0.54
P/B
0.8
EPS (TTM)
$-16.96
CF/Share
$-6.78
Rev Growth 3Y
+19.6%
52W High
$22.80
52W Low
$1.45
$1.45
52-Week Range
$22.80
Financial Health
Free Cash Flow
-$5.9M
Net Debt
$14.1M
Cash
$3.1M
Total Debt
$17.2M
As of Sep 30, 2025
How does BNGO compare to Life Sciences Tools & Services peers?
Peer group: Micro-cap Life Sciences Tools & Services (All) · 44 companies
BNGO valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Undervalued
P/S ratio
0.5
▼
86%
below
peers
(3.7)
vs Peers
vs Industry
Undervalued
P/B ratio
0.8
▼
58%
below
peers
(2.0)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
BNGO profitability vs Life Sciences Tools & Services peers
ROE
-86.4%
▼
250%
below
peers
(-24.7%)
vs Peers
vs Industry
Weak
Net margin
-134.4%
▼
383%
below
peers
(-27.8%)
vs Peers
vs Industry
Weak
Gross margin
46.0%
▼
5%
below
peers
(48.2%)
vs Peers
vs Industry
Weak
ROA
-49.8%
▼
242%
below
peers
(-14.6%)
vs Peers
vs Industry
Weak
BNGO financial health vs Life Sciences Tools & Services peers
D/E ratio
7.5
▼
68%
below
peers
(23.2)
vs Peers
vs Industry
Above avg
Current ratio
2.1
▼
36%
below
peers
(3.3)
vs Peers
vs Industry
Low liquidity
Beta
1.7
▲
23%
above
peers
(1.4)
vs Peers
vs Industry
More volatile
BNGO fundamentals radar
BNGO
Peer median
Industry
BNGO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BNGO vs peers: key metrics
Top Holders
Top 5: 6.88%GSA Capital Partners LLP
3.32%
$392K
DRW Securities, LLC
1.66%
$195K
Vanguard Group Inc
0.81%
$95K
Geode Capital Management, L…
0.66%
$77K
Carret Asset Management, LLC
0.43%
$51K
As of Dec 31, 2025
Latest News
No related news yet